APLLTD Stock View

Alembic Pharmaceuticals Ltd
stock-view-header

₹ 790.75

icon -10.75 | -1.36
Market Cap ₹( Cr.)
155,432.30
Proj. P/E (x)
30.16
Proj. P/BV (x)
3.30
Proj. ROE (%)
11.40
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)
63,008.12

Stock View

HOLD

Last Updated On.
01-Oct-2023
 

The average score for Alembic Pharmaceuticals Ltd stands at 7 against 7, three months back.

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
765.14
100 DMA(₹)
683.47
200 DMA(₹)
609.64
52 Weeks Range
463.30     825.00

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required